TORONTO, Jan. 17, 2019 /PRNewswire/ - The Green Organic
Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD)
(US:TGODF) is pleased to announce the appointment of Dr.
Rav Kumar, PhD as the Company's
Chief Science Officer.
Dr. Kumar will lead The Green Organic Dutchman's Science &
Innovation Division and oversee all aspects of science-related
initiatives including TGOD's science portfolio encompassing
advanced and innovative global product lines for patients and
consumers. Dr. Kumar will help drive innovation from concept to
commercialization at the Company.
With over 25+ years' experience in the pharmaceutical industry,
Dr. Kumar is a seasoned senior executive with international
experience in Europe, Asia and North
America. His career has focussed on discovery, formulation
development, clinical, regulatory, manufacturing, quality &
compliance and business development. Additionally, he has created
several multimillion-dollar industry-academic partnerships and
received the 2014 Award for Leadership in Canadian Pharmaceutical
Sciences.
"We are incredibly excited to welcome Dr. Kumar to TGOD. He is a
proven and seasoned senior executive with extensive international
pharmaceutical experience in developing innovative and novel
products with some of the world's largest pharmaceutical
companies," stated Brian Athaide,
CEO and Director of TGOD. "We believe Dr. Kumar, combined with our
recent additions of Dr. MacCallum and
Jacques Dessureault, establishes a strong foundation for our
science and medical team and will provide leadership in global
organic cannabis to drive premium innovative solutions for both
patients and consumers," continued Athaide.
Previously, Dr. Kumar held various senior leadership roles with
GlaxoSmithKline with assignments in the UK, France and Canada, spanning 25 years. His positions
included Vice President R&D Operations, and Business
Development & Classic Brands. GSK is one of the world's largest
pharmaceutical companies and has a market capitalization of CAD
$129 billion. Dr. Kumar was involved
in the development of numerous global new chemical entities,
vaccines and new products at GSK. Further, Dr. Kumar played a
pivotal role in building GSK's Research and Development capability
in Canada. Additionally, he
conceived and executed a $150M
spin-out of GSK's Vaccines R&D Unit to create Neomed Biologics
and Vaccines Centre of Excellence in Montreal.
Prior to joining TGOD, Dr. Kumar was Managing Director of Apotex
India, Apotex's largest investment outside of Canada and included pharmaceutical R&D and
manufacturing. He was instrumental in establishing "Apotex Global
Business Services" in Mumbai,
providing medical, scientific, and commercial services to Apotex
globally. Dr. Kumar was instrumental in building out a new
leadership team, business processes in addition to strengthening
alignment and relationships with Apotex global operations. Apotex
is Canada's largest private
pharmaceutical company with global annual sales of several billion
dollars.
Dr. Kumar's notable volunteer and board experience includes
President of the Canadian Society for Pharmaceutical Sciences,
board member of CQDM – Pharmaceutical Consortium for Drug Discovery
Platforms, and National Steering Committee for Patient-Oriented
Research (Canadian Institute of Health Research - CIHR) among
others.
He holds a Doctor of Philosophy from the University of
Bath, UK and a Bachelor of
Pharmacy (Honours) from the University of Cardiff, UK.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a
publicly traded, premium global organic cannabis company, with
operations focused on medical cannabis markets
in Canada, Europe, the Caribbean and Latin
America, as well as the Canadian adult-use market. The Company
grows high quality, organic cannabis with sustainable, all-natural
principles. TGOD's products are laboratory tested to ensure
patients have access to a standardized, safe and consistent
product. TGOD has a funded capacity of 170,000 kgs and is building
1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica.
TGOD's Common Shares and warrants issued under the indenture
dated November 1, 2017 trade on the
TSX under the symbol "TGOD" and "TGOD.WT", respectively.
For more information on The Green Organic Dutchman Holdings
Ltd., please visit www.tgod.ca.
www.tgod.ca
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward looking
statements in this release includes, but is not limited to,
statements about the future legalization of cannabis-infused
products in Canada, statements
about future research, development and innovation by the Company,
statements about future facility construction, statements about the
offering of any particular products by the Company in any
jurisdiction and statements regarding the future performance of the
Company. Forward-looking statements are frequently characterized by
words such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These statements are
only predictions. Various assumptions were used in drawing the
conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accept
responsibility for the adequacy or accuracy of this
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/the-green-organic-dutchman-appoints-chief-science-officer-300779607.html
SOURCE The Green Organic Dutchman Holdings Ltd.